
JWBK011-06 JWBK011-Hogg August 12, 2005 16:0 Char Count= 0
154 MICROBIAL METABOLISM
amino acids are broken down, they are likewise broken down into a handful of metabolic
intermediates, which then feed into the TCA cycle.
The regulation of metabolism
Microorganisms, like the rest of us, live in a changing world, and their needs do not
always remain the same. It would be highly inefficient and (frequently wasteful) if all
their metabolic reactions were going on with equal intensity all the time, regardless of
whether they were needed. Over evolutionary time, regulation systems have developed,
so that metabolism is tailored to the prevailing conditions.
Essentially, this regulation involves controlling the activity of enzymes which direct
the many biochemical reactions occurring in each cell. This can be done by:
r
directly affecting enzyme activity, or
r
indirectly, at the genetic level, by controlling the level at which enzymes are
synthesised.
Direct control of enzymatic activity occurs by the mechanism of feedback inhibition
(see Box 6.5), whereby the final product of a metabolic pathway acts as an inhibitor to
the enzyme that catalyses an early step (usually the first) in the pathway. It thus prevents
Box 6.5 Feedback inhibition
Biosynthetic pathways exist as a series of enzyme-mediated reactions, leading to
a final product required by the cell for structural or metabolic purposes. But what
happens if for some reason, the consumption of the final product slows down, or
even stops? Feedback inhibition, also known, perhaps more descriptively, as ‘end-
product inhibition’, ensures that excess amounts of the end product are not synthe-
sised. The pathways leading to the synthesis of many amino acids are regulated
in this way, for example isoleucine, which is synthesised from another amino acid,
threonine, via a series of intermediates:
Threonine Isoleucine
Here, the isoleucine itself acts as an inhibitor of threonine deaminase, the enzyme
which starts off the pathway. It does this by binding to an allosteric site on the enzyme,
distorting it and preventing its active site from binding to threonine. Note, that by
inhibiting the early part of the pathway, we not only prevent further production of
isoleucine but also unnecessary breakdown of threonine. When levels of isoleucine
starts to run low, less will be available to block the threonine deaminase, and thus
the pathway starts to function again.